Department of Anesthesiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, China.
Trials. 2020 Jun 26;21(1):580. doi: 10.1186/s13063-020-04524-7.
Moderate-to-severe postoperative pain following craniotomy has a high incidence in pediatric patients. Such pain may cause agitation, intracranial hypertension, epileptic seizures, and postoperative hematoma, which affect morbidity and mortality. Although scalp nerve block (SNB) achieves satisfactory pain relief except for suboccipital mid-craniotomy in adults and ropivacaine is widely used as a long-acting peripheral nerve block agent in children, there are few studies of SNB with ropivacaine in pediatric patients undergoing craniotomy. In addition, the neurosurgery operation time is relatively long, but the duration of action of SNB is limited. It is generally believed that postoperative SNB is better than preoperative SNB for postoperative analgesia. However, considering the concept of preemptive analgesia, we believe that preoperative SNB may achieve a longer postoperative analgesia effect than we expected.
This trial is a single-institution, prospective, randomized, controlled, double-blind study. A total of 180 children aged between 1 and 12 years who are undergoing elective craniotomy will be randomly allocated in a 1:1:1 ratio to three groups: group B (preoperative ropivacaine block group), group A (postoperative ropivacaine block group), and group N (nonblocking control group). This randomization will be stratified by age in two strata (1-6 years and 7-12 years). The primary outcome is the total consumption of sufentanil within 24 h after surgery. The secondary outcomes include assessment of pain scores, total consumption of sufentanil and emergency-remedy medicine consumption at observation points, the occurrence of postoperative complications, and the length of hospitalization after surgery.
This study is designed to explore the effect and feasibility of SNB with ropivacaine for postoperative analgesia in pediatric patients undergoing craniotomy. Further aims are to compare the effects of preoperative and postoperative SNB on postoperative analgesia in order to identify whether there is a preemptive analgesic effect and determine the better time to implement SNB in pediatric patients during craniotomy.
Chinese Clinical Trial Registry ChiCTR1800017386. Registered on 27 July 2018.
儿童开颅术后中重度疼痛发生率较高。这种疼痛可能导致躁动、颅内压升高、癫痫发作和术后血肿,从而影响发病率和死亡率。虽然头皮神经阻滞(SNB)在成人中除枕下入路开颅术外均可达到满意的止痛效果,罗哌卡因在儿童中广泛用作长效周围神经阻滞药物,但关于罗哌卡因用于行开颅术的儿童 SNB 的研究较少。此外,神经外科手术时间相对较长,但 SNB 的作用持续时间有限。一般认为,术后 SNB 比术前 SNB 更有利于术后镇痛。但是,考虑到超前镇痛的概念,我们认为术前 SNB 可能会产生比我们预期更长的术后镇痛效果。
本试验为单中心、前瞻性、随机、对照、双盲研究。将 180 例 1-12 岁择期行开颅术的儿童随机分为三组:B 组(术前罗哌卡因阻滞组)、A 组(术后罗哌卡因阻滞组)和 N 组(非阻滞对照组),1:1:1 比例。这种随机化将按年龄分为两个层(1-6 岁和 7-12 岁)。主要结局是术后 24 小时内舒芬太尼的总消耗量。次要结局包括观察点疼痛评分、舒芬太尼总消耗量和急救药物消耗量的评估、术后并发症的发生情况以及术后住院时间。
本研究旨在探讨罗哌卡因 SNB 用于儿童开颅术后镇痛的效果和可行性。进一步的目的是比较术前和术后 SNB 对术后镇痛的影响,以确定是否存在超前镇痛作用,并确定在儿童开颅术中实施 SNB 的更好时间。
中国临床试验注册中心 ChiCTR1800017386。于 2018 年 7 月 27 日注册。